Entinostat: a promising treatment option for patients with advanced breast cancer

Connolly, RM; Rudek, MA; Piekarz, R

Connolly, RM (reprint author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.

FUTURE ONCOLOGY, 2017; 13 (13): 1137

Abstract

Entinostat is a synthetic benzamide derivative histone deacetylase (HDAC) inhibitor, which potently and selectively inhibits class I and IV HDAC enzym......

Full Text Link